Company: ARMP
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001104659-25-040273
Chunk: 49

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 49
---
 which was $1.85 per share. (2) The restricted stock units will vest, subject to continuous employment through the vesting date, in substantially equal installments on March 14 th of each of 2025, 2026, 2027 and 2028, subject to accelerated vesting in connection with certain terminations. (3) The options will vest, subject to continuous employment through the vesting date, in substantially equal installments on March 14 th of each of 2025, 2026, 2027 and 2028, subject to accelerated vesting in connection with certain terminations. (4) The options will vest, subject to continuous employment through the vesting date, in substantially equal installments on August 16 th of each of 2025, 2026, 2027 and 2028, subject to accelerated vesting in connection with certain terminations.

32

(5) The restricted stock units will vest, subject to continuous employment through the vesting date, in substantially equal installments on July 10 th of each of 2025, 2026 and 2027, subject to accelerated vesting in connection with certain terminations. (6) The options will vest, subject to continuous employment through the vesting date, in substantially equal installments on July 10 th of each of 2025, 2026 and 2027, subject to accelerated vesting in connection with certain terminations. (7) The options will vest, subject to continuous employment through the vesting date on March 25 th of 2025, subject to accelerated vesting in connection with certain terminations. (8) The options will vest, subject to continuous employment through the vesting date, in substantially equal installments on April 13 th of each of 2025 and 2026, subject to accelerated vesting in connection with certain terminations. (9) All unvested equity awards were forfeited by Dr. Pastagia as of November 13, 2024 in connection with her departure. Her vested options remained outstanding for 90 days following her date of departure. (10) All unvested equity awards were forfeited by Mr. Rychlik as of September 30, 2024 in connection with his departure. His vested options remained outstanding for 90 days following her date of departure, so Mr. Rychlik held no options as of December 31, 2024. Equity Incentive Plans